In early 2019, an esketamine nasal spray was approved by the FDA for adults with treatment-resistant depression. Its FDA-approved uses were later expanded to include patients suffering from acute suicidal ideation. But what is esketamine, and how is it different from regular ketamine?
Microdosing is a common term that has become a part of the cultural vernacular. It is the practice of ingesting a very low dose of a psychedelic substance. A microdose is small enough that it does not impair “normal” functioning, but still has an effect.
In early 2019, an esketamine nasal spray was approved by the FDA for adults with treatment-resistant depression. Its FDA-approved uses were later expanded to include patients suffering from acute suicidal ideation. But what is esketamine, and how is it different from regular ketamine?
Microdosing is a common term that has become a part of the cultural vernacular. It is the practice of ingesting a very low dose of a psychedelic substance. A microdose is small enough that it does not impair “normal” functioning, but still has an effect.
